Innovations

A preview of today's new products.

 

CenterCross Catheter

Roxwood Medical
(650) 779-4555
www.roxwoodmedical.com

KEY FEATURES
• Maximum support for luminal crossing
• Resheathable, self-expanding scaffold
• 3-F inner lumen
• Anchors and centers guidewires and microcatheters

The CenterCross catheter (Roxwood Medical), which received US Food and Drug Administration clearance in November 2014, is designed to simplify guidewire delivery across complex lesions in the peripheral and coronary vasculature. The catheter incorporates a unique selfexpanding scaffold to stabilize off-the-shelf interventional tools, such as guidewires and microcatheters, in the center of the artery near the target lesion.

Upon delivery to the target lesion, the scaffold is deployed to maximize support for a guidewire or microcatheter, which are delivered independently through the central 3-F lumen. Once the guidewire penetrates and successfully crosses the blockage, the scaffold is resheathed and removed, allowing the operator the choice of angioplasty, stenting, or atherectomy.

CenterCross is being used to treat coronary, tibial, popliteal, and superficial femoral artery lesions. “CenterCross is a surprisingly simple and effective tool that provides great wire support for crossing tough lesions,” said Tom Davis, MD, of St. John Hospital in Detroit, Michigan.

Endurant IIs AAA Stent Graft

Medtronic, Inc.
(888) 283-7868
www.aortic.medtronicendovascular.com

KEY FEATURES:
• Bifurcated component of predicate device
• Offers shorter (50-mm) ipsilateral leg
• Designed as a three-piece configuration
• Enables in situ sizing
• Provides up to 20% reduction in distal diameter

Medtronic, Inc. announced the European and United States launch of the Endurant IIs abdominal aortic aneurysm (AAA) stent graft, which recently received CE Mark and US Food and Drug Administration approval to be used in the minimally invasive treatment of AAAs.

The Endurant IIs stent graft is a new bifurcated component for Medtronic’s Endurant AAA stent graft system that leverages the proven design of the predicate device, the Endurant II stent graft, and expands the system’s anatomic customization options. The new device is designed to be used as part of a three-piece configuration. The Endurant IIs stent graft features equal leg diameters to allow limbs to be used on either side; offers a shorter (50-mm) ipsilateral leg for more flexible targeted limb placement; enables in situ sizing with select ipsilateral limbs, allowing a three- to five-stent overlap for adjustment during the implantation procedure; provides up to a 20% reduction in distal diameter compared to select Endurant II stent grafts; and allows easier precase planning by simplifying sizing decisions.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.